{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T02:38:26Z","timestamp":1765939106120,"version":"3.48.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,16]]},"DOI":"10.7759\/cureus.99407","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T02:35:05Z","timestamp":1765938905000},"source":"Crossref","is-referenced-by-count":0,"title":["Tumoral Melanosis: A Benign Mimicker of Malignant Disease"],"prefix":"10.7759","author":[{"given":"Analy","family":"Gomez-Picos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol E","family":"Marquez Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores M","family":"Arellano Vivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Achell Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A","family":"Loredo Alanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.03.008","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022","volume":"170","author":"Garbe C","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, et al.. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer. 2022, 170:236-55. 10.1016\/j.ejca.2022.03.008","journal-title":"Eur J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9235638","article-title":"Immunotherapy in the treatment of metastatic melanoma: current knowledge and future directions","volume":"2020","author":"Ralli M","year":"2020","unstructured":"Ralli M, Botticelli A, Visconti IC, et al.. Immunotherapy in the treatment of metastatic melanoma: current knowledge and future directions. J Immunol Res. 2020, 2020:9235638. 10.1155\/2020\/9235638","journal-title":"J Immunol Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2024.01.011","article-title":"Tumoral melanosis: a case series of patients with metastatic melanoma after systemic immunotherapy","volume":"45","author":"Wix SN","year":"2024","unstructured":"Wix SN, Heberton M, Vandergriff TW, Yancey KB, Gill JG. Tumoral melanosis: a case series of patients with metastatic melanoma after systemic immunotherapy. JAAD Case Rep. 2024, 45:82-7. 10.1016\/j.jdcr.2024.01.011","journal-title":"JAAD Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001612","article-title":"Tumoral melanosis in the setting of targeted immunotherapy for metastatic melanoma: a single institutional experience and literature review","volume":"43","author":"Jurgens A","year":"2021","unstructured":"Jurgens A, Guru S, Guo R, Brewer J, Bridges A, Jakub J, Comfere N. Tumoral melanosis in the setting of targeted immunotherapy for metastatic melanoma: a single institutional experience and literature review. Am J Dermatopathol. 2021, 43:9-14. 10.1097\/DAD.0000000000001612","journal-title":"Am J Dermatopathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14727","article-title":"The prognostic significance of tumoral melanosis","author":"Potter AJ","year":"2024","unstructured":"Potter AJ, Ferguson PM, Lo SN, et al.. The prognostic significance of tumoral melanosis. J Cutan Pathol. 2024, 10.1111\/cup.14727","journal-title":"J Cutan Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14809","article-title":"Tumoral melanosis associated with nivolumab therapy for metastatic melanoma","volume":"20","author":"Arias NM","year":"2022","unstructured":"Arias NM, Pe\u00f1aranda JM, Gaspar LS, Mosquera AC, S\u00e1nchez-Aguilar D. Tumoral melanosis associated with nivolumab therapy for metastatic melanoma. J Dtsch Dermatol Ges. 2022, 20:1130-1. 10.1111\/ddg.14809","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/442859-tumoral-melanosis-a-benign-mimicker-of-malignant-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T02:35:08Z","timestamp":1765938908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/442859-tumoral-melanosis-a-benign-mimicker-of-malignant-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.99407","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,16]]}}}